Company / Assets per Share
Janux Therapeutics, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$16.16
FY2025
5-year range
$8.64 / $19.75
FY2021-FY2025
Trend
-18.2%
vs FY2024
Sector context
#67 of 212
Health Care
What the data says
At $16.16, Janux Therapeutics, Inc.'s assets per share ranks #67 of 212 in the Health Care sector. Improved from $8.64 to $16.16 over the past 2 years.
Based on SEC 10-K filings.
16.16 in FY2025 with a 5-year CAGR of -1.8%.
Improved from $8.64 to $16.16 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +22.6%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Sector benchmark
#67 of 212 in Health CareTop 32% of 212This company $16.16 Sector average $294.36
▼
-94.5% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 18.2% year-over-year.
- Ranks #67 out of 212 companies in the Health Care sector.
- Peak assets per share was recorded in FY2024.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.16 | -18.2% |
| FY2024 | $19.75 | +128.5% |
| FY2023 | $8.64 | -1.5% |
| FY2022 | $8.78 | -45.6% |
| FY2021 | $16.14 | -8.9% |
| FY2020 | $17.72 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026